COVID-19 Testing in Underserved and Vulnerable Populations

COVID-19 Testing in Underserved and Vulnerable Populations

Conditions: Heart Failure; Coronary Artery Disease; Cancer; Chronic Kidney Diseases; COPD; Obesity; Sickle Cell Disease; Diabetes Mellitus, Type 2
Interventions: Other: Community outreach method
Sponsors: Jesse Nodora; National Cancer Institute (NCI)
Terminated

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

February 29, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments